Mostrando 521 - 540 Resultados de 1,014 Para Buscar '"Shareholder"', tiempo de consulta: 0.47s Limitar resultados
  1. 521
    “…Are we experiencing further marketization and privatization—toward a so-called Anglo-Saxon shareholder model—or are we seeing a continuation of the so-called Rhineland, multistakeholder model of government, market, and philanthropy?…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  2. 522
    “…This article highlights how the Italian public shareholder’s system became decisive to increase efficiency in small airports due to the lack of private financing.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  3. 523
    “…This study examined the association between leadership styles (autocrat, consultative autocrat, consensus manager, and shareholder manager) and resident quality and financial performance in under-resourced nursing homes. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  4. 524
    “…Through 2016, BIOTECH and CONTROL companies had equivalent growth in market cap and shareholder value (>$100 billion), but BIOTECH companies had lower net value creation ($93 billion vs $411 billion). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  5. 525
    “…Based on data from Chinese high-tech industry listed companies, the empirical results show that: (1) the largest shareholder’s shareholding ratio has a positive effect on marketing investment psychology and a negative impact on R&D investment psychology, (2) other large shareholdersshareholding ratio are positive related to R&D investment psychology; (3) R&D investment psychology has a negative effect and marketing investment psychology has a positive influence on the current performance; (4) equity counterbalance is positive related to R&D investment psychology and has a negative effect on the current performance. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  6. 526
    por Reynolds, Devon, Ciplet, David
    Publicado 2022
    “…We posit that transformative investment initiatives, including those related to strategies of screening and shareholder resolutions, would reflect three general conditions of environmental justice. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  7. 527
    por Tang, Liang, Gu, Zhen, Zhang, Qi, Liu, Jiali
    Publicado 2022
    “…These findings also provide new insights into the relationship between corporate management and shareholder investment behavior on the level of innovation.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  8. 528
    “…This suggests that a firm’s IR contributes to value generation by enhancing credibility with shareholders and by diversifying its shareholder base. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  9. 529
  10. 530
  11. 531
    “…Manley, Paratek Pharmaceuticals: Employee and Shareholder, Salary. J. N. Steenbergen, Paratek Pharmaceuticals: Employee and Shareholder, Salary. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  12. 532
  13. 533
    “…[Image: see text] Funding: GlaxoSmithKline Biologicals SA DISCLOSURES: Anar Andani, BSc, GSK group of companies (Employee, Shareholder) Eveline M. Bunge, PhD, GSK group of companies (Research Grant or Support) Fernanda Salgado, MD, MSc, GSK group of companies (Employee) Rosa C. van Hoorn, MSc, GSK group of companies (Research Grant or Support) Bernard Hoet, MD, FFPM, GSK group of companies (Shareholder)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  14. 534
    “…Phillips, PhD, BioFire Defense (Employee, Scientific Research Study Investigator, Shareholder)BioFire Defense (Employee, Scientific Research Study Investigator, Shareholder)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  15. 535
  16. 536
    “…DISCLOSURES: Cindy Garris, MSPH, GlaxoSmithKline (Other Financial or Material Support, Stockholder)ViiV Healthcare (Employee) Ronald D’Amico, DO, MSc, GlaxoSmithKline (Shareholder)ViiV Healthcare (Employee) Paul Wannamaker, BA, ViiV Healthcare (Employee) Nobuhle Mpofu, MS, GlaxoSmithKline (Employee, Shareholder) Colleen A. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  17. 537
    “…DISCLOSURES: Patricia De Los Rios, MSc, GlaxoSmithKline (Shareholder)ViiV Healthcare (Employee) Chinyere Okoli, PharmD, MSc, DIP, ViiV Healthcare (Employee) Benjamin Young, MD, PhD, ViiV Healthcare (Employee) Garry Brough, BA Joint Hons in French/Italian, ViiV Healthcare (Employee, Independent Contractor, Other Financial or Material Support, Speakers Fees and Honoraria) Anton Eremin, MD, ViiV Healthcare (Advisor or Review Panel member) Marvelous Muchenje, BSW, MSc. in Global Health, ViiV Healthcare Canada (Employee) Nicolas Van de Velde, PhD, GlaxoSmithKline (Shareholder)ViiV Healthcare (Employee)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  18. 538
  19. 539
  20. 540
Herramientas de búsqueda: RSS